Identification of MEF2-regulated genes during muscle differentiation

Physiological Genomics

Volumn 20, Issue , 2005, Pages 143-151

  Paris, James ^a   Virtanen, Carl ^a   Lu, Zhibin ^a   Takahashi, Mark ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chromatin immunoprecipitation; CpG island microarrays; MEF2

Indexed keywords

COMPLEMENTARY DNA; PROTEIN MEF2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CPG ISLAND; DNA MICROARRAY; GENE AMPLIFICATION; GENE CONTROL; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENOME; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR CLONING; MOUSE; MUSCLE DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CLONING, MOLECULAR; CPG ISLANDS; DNA; DNA PRIMERS; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; GENOME; IMMUNOPRECIPITATION; MICE; MUSCLES; MUTATION; MYOGENIC REGULATORY FACTORS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 15244342227     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00149.2004     Document Type: Article

References (49)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, and Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1997.
2. Antequera F and Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90: 11995-11999, 1993.
3. Bergstrom DA, Penn BH, Strand A, Perry ML, Mudnicki MA, and Tapscott SJ. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell 9: 587-600, 2002.
4. Black BL and Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14: 167-196, 1998.
5. Braun T and Arnold HH. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J 14: 1176-1186, 1995.
6. Breitbart ME, Liang CS, Smoot LB, Laheru DA, Mahdavi V, and Nadal-Ginard B. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 118: 1095-1106, 1993.
7. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler M, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, and Gingeras TR. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499-509, 2004.
8. Cross SH and Bird AP. CpG islands and genes. Curr Opin Genet Dev 5: 309-314, 1995.
9. Cross SH, Lee M, Clark VH, Craig JM, Bird AP, and Bickmore WA. The chromosomal distribution of CpG islands in the mouse: evidence for genome scrambling in the rodent lineage. Genomics 40: 454-461, 1997.
10. Delgado I, Huang X, Jones S, Zhang L, Hatcher R, Gao B, and Zhang P. Dynamic gene expression during the onset of myoblast differentiation in vitro. Genomics 82: 109-121, 2003.
11. Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DA, Lovett FA, Holding C, and Pell JM. Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol 24: 3607-3622, 2004.
12. - cotransport: the SLC12 family. Pflügers Arch 447: 580-593, 2004.
13. Hidaka K, Morisaki T, Byun SH, Hashido K, Toyama K, and Mukai T. The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. Biochem Biophys Res Commun 213: 555-560, 1995.
14. Iyer VR, Horak CE, Scafe CS, Botstein D, Snyder M, and Brown PO. Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 409: 533-538, 2001.
15. Jablonka S, Bandilla M, Wiese S, Buhler D, Wirth B, Sendtner M, and Fischer U. Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy. Hum Mol Genet 10: 497-505, 2001.
16. Jiang BH, Aoki M, Zheng JZ, Li J, and Vogt PK. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad Sci USA 96: 2077-2081, 1999.
17. Johansson O, Alkema W, Wasserman WW, and Lagergren J. Identification of functional clusters of transcription factor binding motifs in genome sequences: the MSCAN algorithm. Bioinformatics 19:I169-I176, 2003.
18. - channel from human skeletal muscles. Am J Physiol Cell Physiol 277: C948-C954, 1999.
19. Kent WJ. BLAT: the BLAST-like alignment tool. Genome Res 12: 656-664, 2002.
20. King AJ, Sun H, Diaz B, Barnard D, Miao W, Bagrodia S, and Marshall MS. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 396: 180-183, 1998.
21. Kuroda S, Oyasu M, Kawakami M, Kanayama N, Tanizawa K, Saito N, Abe T, Matsuhashi S, and Ting K. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochem Biophys Res Commun 265: 79-86, 1999.
22. Laine J, Kunstle G, Obata T, Sha M, and Noguchi M. The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell 6: 395-407, 2000.
23. Li Y, Jiang B, Ensign WY, Vogt PK, and Han J. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell Signal 12: 751-757, 2000.
24. Lumeng C, Phelps S, Crawford GE, Walden PD, Barald K, and Chamberlain JS. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci 2: 611-617, 1999.
25. Mao DY, Watson JD, Yan PS, Barsyte-Lovejoy D, Khosravi F, Wong WW, Farnham PJ, Huang TH, and Penn LZ. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr Biol 13: 882-886, 2003.
26. Mao Z, Bonni A, Xia F, Nadal-Vicens M, and Greenberg ME. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286: 785-790, 1999.
27. McDermott JC, Cardoso MC, Yu YT, Andres V, Leifer D, Krainc D, Lipton SA, and Nadal-Ginard B. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol Cell Biol 13: 2564-2577, 1993.
28. Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, and Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18: 5099-5107, 1999.
29. Miyata Y, Akashi M, and Nishida E. Molecular cloning and characterization of a novel member of the MAP kinase superfamily. Genes Cells 4: 299-309, 1999.
30. Molkentin JD, Black BL, Martin JF, and Olson EN. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136, 1995.
31. Moran JL, Li Y, Hill AA, Mounts WM, and Miller CP. Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. Physiol Genomics 10: 103-111, 2002. First published June 25, 2002; doi:10.1152/physiolgenomics.00011.2002.
32. Nevrivy DJ, Peterson VJ, Avram D, Ishmael JE, Hansen SG, Dowell P, Hruby DE, Dawson MI, and Leid M. Interaction of GRASP, a protein encoded by a novel retinoic acid-induced gene, with members of the cytohesin family of guanine nucleotide exchange factors. J Biol Chem 275: 16827-16836, 2000.
33. Olson EN, Arnold HH, Rigby PW, and Wold BJ. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85: 1-4, 1996.
34. Ornatsky OI, Andreucci JJ, and McDermott JC. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J Biol Chem 272: 33271-33278, 1997.
35. Pollock R and Treisman R. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev 5: 2327-2341, 1991.
36. Rawls A, Morris JH, Rudnicki M, Braun T, Arnold HH, Klein WH, and Olson EN. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis. Dev Biol 172: 37-50, 1995.
37. Sandelin A, Alkema W, Engstrom P, Wasserman WW, and Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32: D91-94, 2004.
38. Shen X, Collier JM, Hlaing M, Zhang L, Delshad EH, Bristow J, and Bernstein HS. Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 226: 128-138, 2003.
39. Sonntag KC, Simantov R, Kim KS, and Isacson O. Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation. Eur J Neurosci 19: 1141-1152, 2004.
40. Suzuki T, K-Tsuzuku J, Ajima R, Nakamura T, Yoshida Y, and Yamamoto T. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 16: 1356-1370, 2002.
41. Tomczak KK, Marinescu VD, Ramoni MF, Sanoudou D, Montanaro F, Han M, Kunkel LM, Kohane IS, and Beggs AH. Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J 18: 403-405, 2004.
42. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, and Yoshimura A. Spred is a Sprouty-related suppressor of Ras signalling. Nature 412: 647-651, 2001.
43. Wasserman WW and Fickett JW. Identification of regulatory regions which confer muscle-specific gene expression. J Mol Biol 278: 167-181, 1998.
44. Weinmann AS, Yan PS, Oberley MJ, Huang TH, and Farnham PJ. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 16: 235-244, 2002.
45. Yan PS, Perry MR, Laux DE, Asare AL, Caldwell CW, and Huang TH. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res 6: 1432-1438, 2000.
46. 2+-induced release of the transcription factor MEF2. Science 286: 790-793, 1999.
47. Yu YT, Breitbart KE, Smoot LB, Lee Y, Mahdavi V, and Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev 6: 1783-1798, 1992.
48. Yun K and Wold B. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr Opin Cell Biol 8: 877-889, 1996.
49. Zhang CL, McKinsey TA, and Olson EN. The transcriptional corepressor MITR is a signal responsive inhibitor of myogenesis. Proc Natl Acad Sci USA 98: 7354-7359, 2001.